FDA Investigator James D Hildreth

James D Hildreth has conducted inspections on 173 sites in 9 countries as of 28 Jan 2020. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
173
Last Inspection Date:
28 Jan 2020
Investigator Role:
FDA Investigator
Redica ID:
100002209
Countries of Inspections:
United States of America, Japan, Germany, France, Switzerland, Italy, Netherlands, Canada, United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with James D Hildreth:
Aaron J Poloni, Abby M Miller, Abigail A Andersen, Alexander M Kay, Althea A Williams, Anderson, Angela Shepas, Angelica G Aziz, Arie R Dyk, Armando Chavez, MS, Ashleigh P Barkans, Astrida B Mattson, Barbara J Rincon, Beau R Lamb, Brenda L Reihing, Brian P Hendrickson, Bruce R Burrell, Calvin K Cook, Carla V Jordan, Carolyn E Barney, Catherine J Laufmann, Cathleen A Carr Sharpe, Celeta S Coves, Charles L Larson, Cheryl D Mccall, Christine M Parmentier, Christopher S Genther, Clint R Van Blaricom, Creighton T Tuzon, Crystal A Harlan, Cynthia L Gorveatt, Dale A Kuenzi, Dan G Eisenbrey, Daniel J Lahar, Darla R Bracy, David J Gomes, Dawn E Barkans, Deborah A Nebenzahl, Dennis G Kawabata, Devon M Shoop, Deyaa Shaheen, Dirk L Lincoln, Dolores E Price, Dolores Harper, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Elizabeth S Howell, Emal Wahab, Eric C Fox, Eric W Anderson, Erica R Mahone, Francis J Eng, Gary L Zaharek, Gloria J Baca, MS, Graham N Giesen, Hanna L Potter, Harmon M Blanch, Heika R Tait, Hugh A Grimoldby, Ian J Thomson, Jacqueline O Snell, Jacqueline S Warner, James A Beaulieu, James A Lane, James I Vik, James W Plucinski, James W Whitney, Jean Brewer, Jean C Colon Lopez, Jeanne M Weishaar, Jeff A Gard, Jeffrey J Leclair, Jeffrey J Thibodeau, Jeffrey N Gerdes, Jeffrey W Shrifter, DPM, Jessica B Clark, Jessica L Johnson, Jocelyn E Massey, John A Hall, John Burr, John E Emmert, Jonathan T Little, Joseph M Hudak, Julia Ventura, Julian C Hanson, Katelyn Astaub Zamperini, Kathleen S Tormey, Kathryn A Krentz, Kelly D Sheppard, Kelsey M Bishop, Kimberly Lewandowski Walker, Kristina M Phelps, Kurt M Hafer, Lance D Johnson, Lauren E Swantko, Lawrence Y Lee, PhD, Leon R Marquart, Leonard H Lavi, Leya A Grosch, Liliane Brown, Lisa K Capron, Lori J Jennings, Lori J Silverstein, Lorna F Jones, Mai Hang, Maida Henesian (NMI), Marc S Neubauer, Margo C Jones, Mark E Chan, Mark E Moen, Mark L Collins, Mark S Crippen, Mark W Babbitt, Marlo Ianm Alintanahin, Marsha L Mccauley, Matthew A Walburger, Matthew M Vernon, Michael J Lackey, Michael S Hudson, Mike Govro, Nancy A Saxenian Emmons, Nancy E Byerly, Nancy E Doyle, Neil J Traaen, Norman Wong, Orval D Mcintire, Othello G Capangpangan, Patrick R Brown, Paul F Rader, Paul M Kawamoto, Paul R Whitby, Paul Rader, Paula J Wilkerson, Peter Kessler, PhD, Peter T Regan, Philip E Ake, Phillip M Pontikos, Randall F Albright, Richard Jay Tucker, RS, Robert D Tollefsen, Robert S Sweeton, Roger F Zabinski, Ronald E Gill, Rowena S Nguyen, Ryan J Lubert, S Lori Brown, PhD MPH, Salvatore N Randazzo, Sandra L Shire, DMD, MPA, Sangeeta M Khurana, PhD, Sara H Gabel, Scott A Nabe, Scott K Zika, Sergio Chavez (NMI), Shafiq S Ahadi, Shannon J Hall, Sharon I Gundersen, Shelagh D Schopen, Sherri N Rohlf, MD, Sonia R Peterson, Stanley B Eugene, BS, BME, Stephanie L Kelly, Stephen D Eich, Stephen R Souza, Suyang Qin, Suzie L Kent, Tamara S Rosbury, Terri L Dodds, Thai T Duong, Thomas A Peter, Thomas C Mclean, CFS, Thomas R Beilke, Tiki J Dixon, Timothy C Grome, Timothy D Evans, Timothy S Williamson, Tonia L Sawyer, Tracy K Li, Vanessa Y Jacobs, Victor A Meo, Wanda J Torres, William C Hughes, Xiaojun Yan, Young M Yoon, Yvette E Guillermo, Zachary P Wachlarowicz

James D Hildreth's Documents

Publish Date Document Type Title
September, 2017 FDA 483 Good Clean Love, Inc. - Form 483, 2017-09-29
May, 2017 FDA 483 Acumed LLC - Form 483, 2017-05-11
December, 2015 FDA 483 SweetSpot Diabetes Care, Inc. - Form 483, 2015-12-18
September, 2013 FDA 483 James W. Baker, MD - Form 483, 2013-09-19
November, 2015 FDA 483 RevMedx, Inc. - Form 483, 2015-11-23
July, 2013 FDA 483 Xtant Medical Holdings Inc - Form 483, 2013-07-12
June, 2017 FDA 483 Columbia Scientific Development LLC - Form 483, 2017-06-07
September, 2016 FDA 483 Ashitaka Factory of Terumo Corporation - Form 483, 2016-09-01
June, 2014 FDA 483 CompView Medical, LLC - Form 483, 2014-06-20
January, 2017 FDA 483 Vidco, Inc. - Form 483, 2017-01-12
September, 2012 FDA 483 Welch Allyn Protocol, Inc - Form 483, 2012-09-26
July, 2012 EIR Bacterin International, Inc. - EIR, 2012-07-27
August, 2017 FDA 483 BZ Medical, Inc. - Form 483, 2017-08-15
July, 2012 EIR Xtant Medical Holdings Inc - EIR, 2012-07-26
September, 2017 FDA 483 BioModeling Solutions, Inc. - Form 483, 2017-09-11
September, 2013 FDA 483 Response James W. Baker, MD - Form 483R, 2013-10-08
January, 2015 FDA 483 OR Specific, Inc. - Form 483, 2015-01-08
December, 2015 FDA 483 Response SweetSpot Diabetes Care, Inc. - Form 483R, 2016-01-08
May, 2011 FDA 483 Willamette Egg Farms LLC - Form 483, 2011-05-06
April, 2016 EIR Semler Technologies Inc - EIR, 2016-04-18
November, 2014 FDA 483 DORO INC ( O/S DORO SAFETY & SECURITY) - Form 483, 2014-11-13
November, 2012 FDA 483 Precision Interconnect, LLC dba TE Connectivity Medical - Form 483, 2012-11-16
May, 2011 FDA 483 M.G. Waldbaum Company dba Williamette Egg Farm - Satrum - Form 483, 2011-05-11
December, 2014 FDA 483 Pedigo Products, Inc. - Form 483, 2014-12-12
April, 2018 FDA 483 Tricol Biomedical, Inc. - Form 483, 2018-04-02
March, 2013 FDA 483 Inovise Medical, Inc. - Form 483, 2013-03-21
May, 2013 FDA 483 BIOTRONIK Inc - Form 483, 2013-05-06
April, 2014 FDA 483 Spacelabs Healthcare Inc - Form 483, 2014-04-02
April, 2016 FDA 483 Semler Technologies Inc - Form 483, 2016-04-18
March, 2015 FDA 483 The Seaberg Company, Inc. dba SAM Medical Products - Form 483, 2015-03-10
March, 2015 FDA 483 NDS Surgical Imaging LLC - Form 483, 2015-03-25
November, 2014 FDA 483 Storz Medical, AG - Form 483, 2014-11-21
May, 2018 FDA 483 Meditherm Inc. - Form 483, 2018-05-30
March, 2016 FDA 483 US Vascular, Inc. - Form 483, 2016-03-28
February, 2013 FDA 483 Riverpoint Medical, LLC - Form 483, 2013-02-04
July, 2012 FDA 483 Vidco, Inc. - Form 483, 2012-07-02
April, 2014 FDA 483 Carousel Solutions LLC dba Xtract Solutions - Form 483, 2014-04-24
January, 2013 FDA 483 Vanguard EMS, Inc. - Form 483, 2013-01-15
September, 2017 FDA 483 Dental Components LLC - Form 483, 2017-09-15
August, 2014 FDA 483 Paragon Vision Sciences, Inc. - Form 483, 2014-08-20
February, 2015 FDA 483 Maloney's Custom Ocular Prosthetics - Form 483, 2015-02-26
January, 2017 FDA 483 Response Vidco, Inc. - Form 483R, 2017-02-02
July, 2012 FDA 483 Xtant Medical Holdings Inc - Form 483, 2012-07-26
May, 2014 FDA 483 Greatbatch Ltd - Form 483, 2014-05-16
July, 2014 FDA 483 Beevers Manufacturing & Supply, Inc. - Form 483, 2014-07-07
June, 2016 FDA 483 Blood Bank Computer Systems, Inc. - Form 483, 2016-06-16
August, 2014 FDA 483 MED-Fibers, Inc. - Form 483, 2014-08-22
March, 2017 FDA 483 Almore International Inc - Form 483, 2017-03-23
November, 2015 FDA 483 TZ Medical, Inc. - Form 483, 2015-11-03
June, 2014 FDA 483 Frye Electronics, Inc. - Form 483, 2014-06-03
July, 2012 FDA 483 Bacterin International, Inc. - Form 483, 2012-07-27
September, 2013 EIR James W. Baker, MD - EIR, 2013-09-19
April, 2014 EIR Spacelabs Healthcare Inc - EIR, 2014-04-02
January, 2014 FDA 483 Sonivate Medical, Inc. - Form 483, 2014-01-23
April, 2015 FDA 483 American Medical Systems Innovations - Form 483, 2015-04-03
April, 2017 FDA 483 Response US Vascular, Inc. - Form 483R, 2017-05-17
December, 2013 FDA 483 Tricol Biomedical, Inc. - Form 483, 2013-12-18
April, 2013 FDA 483 ACUTE Innovations, LLC - Form 483, 2013-04-19
April, 2017 FDA 483 US Vascular, Inc. - Form 483, 2017-04-24
February, 2015 FDA 483 Genesis Northwest, Incorporated - Form 483, 2015-02-13

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more